Deutsch English Français

Contact

EP3765054

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3765054

EP3765054 - COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T CELLS WITH CHIMERIC ANTIGEN RECEPTORS [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 30.05.2024 Database last updated on 03.10.2024
Former	Request for examination was made Status updated on 18.12.2020
Former	The international publication has been made Status updated on 27.07.2019
Most recent event Tooltip	30.09.2024	New entry: Reply to examination report
Applicant(s)	For all designated states The Trustees of The University of Pennsylvania 3160 Chestnut Street Suite 200 Philadelphia, PA 19104 / US
	[2021/03]
Inventor(s)	01 / PAYNE, Aimee S. 536 Hamilton Road Merion Station, Pennsylvania 19066 / US
	02 / ELLEBRECHT, Christoph T. 500 Admirals Way, Apt. 226 Philadelphia, Pennsylvania 19146 / US
	[2021/03]
Representative(s)	Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE
	[2021/03]
Application number, filing date	19741698.5	18.01.2019
	[2021/03]
	WO2019US14227
Priority number, date	US201862619146P	19.01.2018 Original published format: US 201862619146 P
	[2021/03]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2019143961
	Date:	25.07.2019
	Language:	EN
	[2019/30]
	Type:	A2 Application without search report
	No.:	EP3765054
	Date:	20.01.2021
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 25.07.2019 takes the place of the publication of the European patent application.
	[2021/03]
Search report(s)	International search report - published on:	US	16.04.2020
	(Supplementary) European search report - dispatched on:	EP	10.12.2021
Classification	IPC:	A61K38/00, A61K39/00, A61K39/395, A61P35/00, A61P37/00, C07K16/28, // C07K16/30	[2022/02]
	CPC:	C07K16/2809 (EP,US); A61K35/17 (US); A61K39/4611 (EP); A61K39/4631 (EP); A61K39/4632 (EP); A61K39/464412 (EP); (+) A61K48/00 (EP); A61P35/00 (US); C07K14/7051 (EP,US); C07K14/70517 (EP,US); C07K14/70578 (US); A61K2239/28 (EP); A61K2239/31 (EP); A61K2239/38 (EP); C07K2317/56 (US); C07K2317/622 (EP,US); C07K2319/02 (EP,US); C07K2319/03 (EP,US); C07K2319/33 (EP) (-)
	Former IPC [2021/03]	A61K38/00, A61K39/00, A61K39/395, A61P35/00, A61P37/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/03]
Title	German:	ZUSAMMENSETZUNGEN UND VERFAHREN ZUM TARGETING VON GAMMA-DELTA-T-ZELLEN MIT CHIMÄREN ANTIGENREZEPTOREN	[2021/03]
	English:	COMPOSITIONS AND METHODS FOR TARGETING GAMMA DELTA T CELLS WITH CHIMERIC ANTIGEN RECEPTORS	[2021/03]
	French:	COMPOSITIONS ET MÉTHODES DE CIBLAGE DE LYMPHOCYTES T GAMMA DELTA AU MOYEN DE RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES	[2021/03]
Entry into regional phase	05.11.2020	National basic fee paid
	05.11.2020	Search fee paid
	05.11.2020	Designation fee(s) paid
	05.11.2020	Examination fee paid
Examination procedure	deleted	Deletion: Application deemed to be withdrawn, date of legal effect [2021/03]
	09.09.2020	Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time [2021/03]
	05.11.2020	Examination requested [2021/03]
	11.07.2022	Amendment by applicant (claims and/or description)
	29.05.2024	Despatch of a communication from the examining division (Time limit: M04)
	30.09.2024	Reply to a communication from the examining division
Request for further processing for:	The application is deemed to be withdrawn due to non-payment of the search fee
	05.11.2020	Request for further processing filed
	05.11.2020	Full payment received (date of receipt of payment) Request granted
	25.11.2020	Decision despatched
	05.11.2020	Request for further processing filed
	05.11.2020	Full payment received (date of receipt of payment) Request granted
	25.11.2020	Decision despatched
	The application is deemed to be withdrawn due to non-payment of the filing fee
	05.11.2020	Request for further processing filed
	05.11.2020	Full payment received (date of receipt of payment) Request granted
	25.11.2020	Decision despatched
	The application is deemed to be withdrawn due to non-payment of the examination fee
	05.11.2020	Request for further processing filed
	05.11.2020	Full payment received (date of receipt of payment) Request granted
	25.11.2020	Decision despatched
	05.11.2020	Request for further processing filed
	05.11.2020	Full payment received (date of receipt of payment) Request granted
	25.11.2020	Decision despatched
	The application is deemed to be withdrawn due to non-payment of designation fees TR, SM, SK, SI, SE, RS, RO, PT, PL, NO, NL, MT, MK, MC, LV, LU, LT, IT, IS, IE, HU, HR, GR, GB, FR, FI, ES, EE, DK, DE, CZ, CY, CH, BG, BE, AT, AL
	05.11.2020	Request for further processing filed
	05.11.2020	Full payment received (date of receipt of payment) Request granted
	25.11.2020	Decision despatched
Fees paid	Renewal fee
	13.01.2021	Renewal fee patent year 03
	14.01.2022	Renewal fee patent year 04
	30.12.2022	Renewal fee patent year 05
	27.12.2023	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]WO2015132598 (UCL BUSINESS PLC [GB]) [Y] 1-22 * claims 1-19 ** the whole document *;
		[Y]US2016175358 (JAKOBOVITS AYA [US], et al) [Y] 1-22 * paragraphs [0009] , [0010]; example 17; claims 14,21, 141,148 *;
		[IY]WO2016172606 (BAYLOR COLLEGE MEDICINE [US]) [I] 1-22 * paragraphs [0004] , [0006]; figure 1; claims 1-78 * [Y] 1-22;
		[Y] - KOENECKE CHRISTIAN ET AL, "In vivo application of mAb directed against the [gamma][delta] TCR does not deplete but generates "invisible" [gamma][delta] T cells", EUROPEAN JOURNAL OF IMMUNOLOGY, (20090201), vol. 39, no. 2, doi:10.1002/eji.200838741, ISSN 0014-2980, pages 372 - 379, XP055865175 [Y] 1-22 * the whole document * * page 376, column r, paragraph 2 * DOI: http://dx.doi.org/10.1002/eji.200838741
		[Y] - JIANHUA ZHOU ET AL, "Anti- TCR antibody-expanded T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies", CELLULAR, London, (20110613), vol. 9, no. 1, doi:10.1038/cmi.2011.16, ISSN 1672-7681, pages 34 - 44, XP055559094 [Y] 1-22 * the whole document * * page 37, column r, paragraph 4 - paragraph 5 * * page 35, column r, paragraph l * DOI: http://dx.doi.org/10.1038/cmi.2011.16
	International search	[A]WO9303151 (MEDICAL RES COUNCIL [GB]) [A] 1-47 * entire document *;
		[A]WO2008118324 (MACROGENICS INC [US], et al) [A] 1-47 * entire document *;
		[A]WO2012154201 (HARVARD COLLEGE [US], et al) [A] 1-47 * entire document *;
		[A]US2014234348 (SCHOLLER NATHALIE [US], et al) [A] 1-47* entire document *;
		[Y]WO2016025880 (NOVARTIS AG [CH], et al) [Y] 6-8, 10, 11, 26, 27, 29 * entire document *;
		[Y]US2016175358 (JAKOBOVITS AYA [US], et al) [Y] 36, 37, 39 * entire document *;
		[Y]WO2016172606 (BAYLOR COLLEGE MEDICINE [US]) [Y] 43-47 * entire document *;
		[XY]WO2016185035 (CELLECTIS [FR]) [X] 1, 9, 12, 13, 15, 18, 21-24, 28, 30-32, 34, 38, 40, 41 * entire document * [Y] 6-8, 10, 11, 16, 17, 19, 20, 26, 27, 29, 33, 35-37, 39, 42-47;
		[A]US2017073430 (BOONTANRART MANDY [US], et al) [A] 1-47 * entire document *;
		[A]WO2017112741 (NOVARTIS AG [CH], et al) [A] 1-47 * entire document *;
		[Y]US2017290858 (ZHAO YANGBING [US], et al) [Y] 42 * entire document *;
		[A]WO2017181119 (NOVARTIS AG [CH], et al) [A] 1-47 * entire document *;
		[Y]US2017334967 (SIEGEL DONALD L [US], et al) [Y] 16, 17, 19, 20, 33, 35 * entire document *;
		[A] - TORIKAI et al., "A Foundation for Universal T- Cell Based Immunotherapy: T Cells Engineered to Express a CD 19-Specific Chimeric-Antigen-Receptor and Eliminate Expression of Endogenous TCR", Blood, (20120614), vol. 119, no. 24, doi:10.1182/blood-2012-01-405365, pages 5697 - 5705, XP055546827 [A] 1-47 * . entire document * DOI: http://dx.doi.org/10.1182/blood-2012-01-405365

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p